Absolute Return Capital
ANAC

Absolute Return Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Absolute Return Capital’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,222
Closed -$482K – 675
2015
Q2 		$482K Buy
+6,222
New +$408K 0.02% 426

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VHCP Management
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Eagle Asset Management
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Rho Capital Partners
Rho Capital Partners New York $20.4M AUM

Absolute Return Capital's ANAC Position: Q3 2015 in Review

Absolute Return Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 6,222 shares — an estimated $482K sold.

Absolute Return Capital first reported a position in ANAC in Q2 2015 and held it in 1 quarter. The position peaked at $482K in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Absolute Return Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Absolute Return Capital sold 6,222 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $482K.
  • Absolute Return Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 1 quarter.
  • Absolute Return Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $482K in Q2 2015.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.